Table 1.
Basic patient cohort information
| Parameters | Survivors (n = 12) | Non-survivors (n = 38) |
|---|---|---|
| Sex (Male/Female) | 4/8 | 21/17 |
| Nationality | 10/2 | 8/30 |
| Lymphoma | 25% | 36.80% |
| Epstein-Barr virus infection | 25% | 23.70% |
| Autoimmune disorders | 8.30% | 5.30% |
| Unknown triggers | 41.70% | 34.20% |
| Age (years) Median (IQR) | 28 (16.0-54.0) | 42.5 (16.0-76.0) |
| Temperature (°C) Median (IQR) | 39.45 (36.20-42.00) | 39.5 (36.50-41.00) |
| WBC (×109/L) Median (IQR) | 2.25 (1.40-10.60) | 3.07 (0.50-25.90) |
| HGB (g/L) Median (IQR) | 109.5 (71.00-163.00) | 98 (45.00-600.00) |
| PLT (×109/L) Median (IQR) | 76.5 (15.00-354.00) | 35 (8.00-177.00) |
The proportion of patients with lymphoma, Epstein-Barr virus infection, and autoimmune diseases in the study cohort. And the distribution of patient age, gender, ethnicity, body temperature at the first visit, WBC, HGB, PLT in the study cohort.